Company intelligence / Profile preview

ProMed funds

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

ProMed Management is a healthcare-focused venture capital firm that invests in early-to-late-stage life science companies. Founded in 2001, the firm primarily targets innovative medical technologies, biotechnology, and healthcare services across the United States and Israel. ProMed leverages its deep clinical and operational expertise to support portfolio companies in navigating regulatory pathways and achieving commercial success. The firm manages multiple investment funds, often referred to as the ProMed funds, which have backed numerous successful exits in the medical device and biopharmaceutical sectors.

Industry: Investors

Beyond the preview

Go deeper on ProMed funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProMed funds.

Explore the full profile